More discount financing. No warrants, but a 12% discount to Friday's close:
>>Barrier Therapeutics to Raise $31.9 Million in Registered Direct Offering of Common Stock
Monday September 24, 8:57 am ET
PRINCETON, NJ--(MARKET WIRE)--Sep 24, 2007 -- Barrier Therapeutics, Inc. (NasdaqGM:BTRX - News), a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that it has priced a registered direct offering of its common stock for approximately $31.9 million in gross proceeds. Under the terms of the financing, Barrier will sell approximately 5.5 million shares of its common stock at $5.75 per share to a select group of institutional investors. All shares of the common stock offered by Barrier Therapeutics are pursuant to an effective registration statement filed with the Securities and Exchange Commission on May 17, 2006. The closing of the offering is scheduled to occur on or about September 26, 2007 and is subject to customary closing conditions.
J. P. Morgan Securities Inc. acted as the exclusive placement agent and Pacific Growth Equities, LLC acted as financial advisor. Copies of the prospectus supplement and accompanying base prospectus relating to this offering may be obtained from J. P. Morgan Securities Inc., at 270 Park Avenue, New York, New York 10172.<<
snip
Haven't followed the company at all.
Cheers, Tuck |
